HEALTHSTORY 652· JUNE 26, 2026

Delphia Therapeutics Names David Kerstein as Chief Medical Officer

Delphia Therapeutics has appointed David Kerstein as its chief medical officer. Kerstein arrives with direct experience in the role, having previously served as CMO at both IDRx and Theseus Pharmaceuticals — a track record that matters in…

NDNewsDialy Desk1 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 651Democratic Senators Push FCC to Freeze Paramount-Warner Bros Discovery Merger on Foreign Ownership Grounds NEXT STORY 653 →Four Ethereum Early Adopters Cash Out 37,602 ETH, Walking Away With $27M After $150M Peak Evaporated

Keep reading

More from the desk.

08HEALTH

Splitting the MMR vaccine risks more missed doses and more sick children, history suggests

Separating the MMR vaccine into individual shots is likely to produce more missed doses and more sick kids. The MMR is a single injection covering measles, mumps, and rubella. It is now the target of a White House executive order

health2 MIN

10HEALTH

FDA Rejects ITM's Cancer Drug on Manufacturing Grounds, Blocking Novartis Rival

A manufacturing problem flagged by U.S. regulators has halted a radiopharmaceutical, a cancer therapy that works by delivering radioactive isotopes directly to tumor cells. The drug's maker, ITM Isotope Technologies Munich SE, had already…

health2 MIN

31HEALTH

States must begin notifying Medicaid enrollees about new work requirements and eligibility rules in September

People covered by Medicaid, the joint federal-state health insurance program for low-income individuals, face new enrollment rules that take effect in 2027. The One Big Beautiful Bill Act of 2025 introduced those changes on what the law…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk